DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $38,765,000 | +24.4% | 293,633 | -2.8% | 0.05% | +9.1% |
| Q4 2018 | $31,156,000 | -15.8% | 302,135 | -11.3% | 0.04% | +2.3% |
| Q3 2018 | $37,022,000 | +7.2% | 340,713 | -2.7% | 0.04% | +4.9% |
| Q2 2018 | $34,550,000 | +2.3% | 350,122 | +1.5% | 0.04% | -2.4% |
| Q1 2018 | $33,787,000 | -1.2% | 345,074 | -6.4% | 0.04% | +2.4% |
| Q4 2017 | $34,213,000 | -46.0% | 368,595 | -50.1% | 0.04% | -47.4% |
| Q3 2017 | $63,355,000 | -37.4% | 738,577 | -38.4% | 0.08% | -37.6% |
| Q2 2017 | $101,131,000 | -19.8% | 1,198,373 | -18.7% | 0.12% | -18.3% |
| Q1 2017 | $126,079,000 | -10.5% | 1,474,093 | -18.5% | 0.15% | -14.0% |
| Q4 2016 | $140,826,000 | -26.1% | 1,809,172 | -25.5% | 0.18% | -25.5% |
| Q3 2016 | $190,441,000 | -19.5% | 2,429,400 | +3.7% | 0.24% | -22.9% |
| Q2 2016 | $236,642,000 | +2.0% | 2,342,988 | -4.2% | 0.31% | +0.6% |
| Q1 2016 | $232,068,000 | -30.1% | 2,446,397 | -31.6% | 0.31% | +45.3% |
| Q4 2015 | $332,197,000 | +352.8% | 3,576,507 | +315.4% | 0.21% | +114.1% |
| Q3 2015 | $73,371,000 | -2.6% | 861,062 | -2.2% | 0.10% | +15.1% |
| Q2 2015 | $75,355,000 | +6.9% | 880,417 | +6.0% | 0.09% | +8.9% |
| Q1 2015 | $70,497,000 | +14.4% | 830,350 | +15.4% | 0.08% | +14.5% |
| Q4 2014 | $61,650,000 | +35.8% | 719,280 | +20.4% | 0.07% | +38.0% |
| Q3 2014 | $45,407,000 | – | 597,630 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |